10 stories about Immunai
Generative AI Chip

Holiday reading recommendation: 7 tech leaders using AI for social impact

11.04.23|Michael Matias and Betty Elbert
The recent calls to stop the development of systems based on artificial intelligence (AI) due to "fundamental risk to humanity" led us to return to interviews with several leaders who make a contribution to humanity thanks to AI technologies.
Noam Solomon Immunai

When not knowing is a methodology

05.01.22|Noam Solomon
"When your culture celebrates that knowledge always starts from the lack thereof, people are rewarded for asking the right questions and not just for knowing the answers," writes Noam Solomon, CEO & Co-Founder of Immunai
ועידת היוניקורנס  Noam Solomon

“What we are building is the Google Maps for the human immune system”

16.12.21|James Spiro
Speaking at the Unicorn Forum, Noam Solomon, CEO of Immunai, outlined an exciting prospect for the future of human health
פורום היוניקורנס פאנל לצמוח למכור להנפיק מימין סופי שולמן הדר צייטלין עמית בן דב אור לנצ'נר ו נועם סולומון

Bright Data CEO: “We have crossed $100 million in annual revenue"

12.12.21|Maayan Manela
“We acquired three companies from the money in our account without requiring any external funding just this year,” said Or Lenchner, speaking on a panel with Gong CEO Amit Bendov, Immunai CEO Noam Solomon and Hailo’s Hadar Zeitlin
מייסדי Immunai מימין לואיס וולוך ו נועם סולומון

Biotech startup Immunai earns unicorn status with $215 million Series B

27.10.21|Meir Orbach
The Israeli company has developed a technological platform that maps the entire immune system for better detection, diagnosis, and treatment of disease
Luis Voloch

“The intersection of machine learning and biology is the future, and we want to be one of the first companies really helping push that forward.”

Luis Voloch joins Michael Matias to discuss how Immunai is reprograming our immune systems and improving the biology of our bodies
צביקה אורון ויולה ונצ'רס

Viola Ventures is Seeking Technologies that Combine AI and Fundamental Scientific Disciplines

02.06.20|Allon Sinai
After investing in Immunai, Zvika Orron is hungry for more of the same formula
מימין נועם סולומון ו לואיס וולוך

Immunai Announces $20 Million Seed Round to Fund Immune System Mapping

14.05.20|Hagar Ravet
The company employs more than 30 workers in Israel and New York and collaborates with more than 10 world-leading medical centers and bio-pharma companies